Specialist bioactive growth factor protein manufacturer Qkine today announced a new partnership with StemCultures, a life sciences company dedicated to developing innovative reagents that enhance the quality and efficiency of cell growth and differentiation in culture.
The manufacture of cell and gene therapy products and tissue-engineered regenerative medicine products often requires recombinant proteins such as growth factors and cytokines. These are classified as raw or ancillary materials ie. culture media components or reagents that are not intended to be included in the final product.
In this edition, we are excited to announce our complete transition to animal origin-free (AOF) manufacturing for all recombinant proteins. This ensures the highest quality and consistency for researchers relying on these critical components. Additionally, discover our latest application notes featuring AOF BDNF and GDNF for neural differentiation and thermostable FGF-2 and TGF-β1 for weekend-free iPSC culture.
We've recently fully transitioned to an animal origin-free (AOF) manufacturing process for our recombinant proteins. This shift ensures the highest standards of safety, purity, and sustainability in bioproduction. By eliminating all animal-derived components, including heparin-based purification columns, we’re supporting ethical and cruelty-free biomanufacturing. Learn more about our journey to 100% AOF.
In this edition, explore our latest data on TGF-beta family proteins designed to facilitate faster optimization of cell culture media. Additionally, you will find other resources to support your research, learn about our upcoming events, and much more.
Welcome to our first newsletter of the year, where we will be highlighting new additions to our portfolio, resources to help your research, our latest promotional offer and upcoming event.
This edition highlights some of our latest resources and products. These include our high-purity mouse/rat Noggin, our newly launched Flt3L (Qk087) to our growing hematopoietic stem cell range and our latest blog on liver organoids emerging as a transformative model for malaria drug discovery.
This edition highlights some of our latest resources and products. These include a case study comparing mTESR, Stem Flex and media containing Qkine thermostable FGF2-G3 (Qk053), our high purity CNTF, and newly launched GM-CSF (Qk076) to our growing hematopoietic stem cell range. We are also excited to announce a new distribution agreement in the US with Thomas Scientific and a 30% discount for new customers for three months.
To support customers working on neural stem cells and glial cells, we have launched CNTF which is animal-free and highly bioactive for improved reproducibility in neural stem cell cultures. We have linked some useful resources, including a new neural on-demand webinar on ‘Advancements in Neurobiology Modeling’. Finally, learn about the first of our on-site stocking partnerships which allow customers same-day access to our products to provide the best and fastest service possible.
This month we launched FGF-1 to our expanding portfolio of animal-free growth factors and cytokines for the proliferation, migration, and differentiation of mesenchymal cells. We announced a new partnership focused on novel and sustainable food manufacturing systems and we also appointed a new European distribution partner, CliniSciences. Learn more in this edition of our Pep Talk.
© 2024 Qkine Ltd. Company number 10470662 registered in England and Wales. All rights reserved
